The company aims to operate an institute for the performance of medical diagnostics and disease prevention in the field of clinical pathology with a focus on the areas of mammary, gynecological, and cytopathology as well as associated molecular pathological examinations. The company may acquire, hold, manage, use, encumber, dispose of, otherwise deal with, sublicense, exploit, or have exploited immaterial property rights, industrial property rights, or license rights. The company may acquire, encumber, dispose of, and manage real estate both domestically and abroad. It may also conduct financing transactions, grant loans to third parties as well as to the shareholders of the company and group companies, and provide securities of all kinds for their obligations to third parties, including pledges, security transfers, and guarantees, even if these loans or securities are in the sole interest of its shareholders or other group companies and are granted free of charge. The company may establish branches and subsidiaries both domestically and abroad, and participate in or merge with other companies both domestically and abroad, as well as conduct all business that is directly or indirectly related to its purpose or suitable to promote it.